Lung Cancer Surgery Market to Grow with a CAGR of 5.36% through 2031

Increase in the incidence and prevalence of lung cancer and increase in the aging population is expected to drive the Global Lung Cancer Surgery Market growth in the forecast period, 2027-2031.

According to TechSci Research report, “Lung Cancer Surgery Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F”, the Global Lung Cancer Surgery Market will grow from USD 6.72 Billion in 2025 to USD 9.19 Billion by 2031 at a 5.36% CAGR. Advancements in surgical techniques, personalized medicine, and multidisciplinary care models can drive this. Lung cancer remains a significant global health challenge, with high incidence rates prompting innovative treatment approaches. Lung cancer surgery encompasses a range of surgical interventions aimed at removing tumors and managing disease progression. Key trends include the increasing adoption of minimally invasive techniques such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS). These approaches offer patients reduced postoperative pain, shorter recovery times, and improved surgical outcomes compared with traditional open surgery.

Personalized medicine is revolutionizing lung cancer treatment by tailoring therapies to individual patient profiles, leveraging molecular diagnostics and genomic profiling. These advancements allow healthcare providers to select targeted therapies and immunotherapies that effectively combat specific genetic mutations and biomarkers associated with lung cancer. Multidisciplinary care models are enhancing treatment coordination among specialists, including surgeons, medical oncologists, radiation oncologists, and pulmonologists. This collaborative approach ensures comprehensive patient management from diagnosis through to post-operative care, optimizing treatment outcomes and patient satisfaction.   

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Lung Cancer Surgery Market”

The Global Lung Cancer Surgery Market is segmented by type, end user, region, and company.

Among end users, hospitals hold a leading position in the lung cancer surgery market, primarily due to their comprehensive capabilities, specialized infrastructure, and capacity to manage complex medical procedures and patient needs effectively. Lung cancer surgery encompasses a spectrum of interventions, ranging from minimally invasive procedures to extensive thoracic surgeries, such as lobectomy or pneumonectomy, which require advanced surgical expertise and intensive post-operative care.

Moreover, hospitals offer a wide array of specialized medical resources essential for lung cancer surgery. These include state-of-the-art operating rooms equipped with advanced surgical instruments, imaging technologies (such as CT scanners and MRI machines), and intensive care units (ICUs) capable of managing potential complications during and after surgery. Such facilities are crucial for ensuring patient safety and optimizing surgical outcomes, particularly in cases involving comorbidities or complex surgical interventions. On the other hand, the multidisciplinary nature of hospital settings supports comprehensive care for patients with lung cancer. Hospitals typically house multidisciplinary teams comprising thoracic surgeons, oncologists, pulmonologists, anesthesiologists, nurses, and other healthcare professionals who collaborate to develop personalized treatment plans and provide integrated care throughout the surgical journey. This collaborative approach ensures that patients receive not only surgical expertise but also coordinated perioperative care, including pre-operative assessment, intraoperative monitoring, and post-operative rehabilitation.

Major companies operating in Global Lung Cancer Surgery Market are:

• Accuray Inc.
• AngioDynamics Inc.
• Johnson & Johnson Services, Inc.
• Intuitive Surgical Inc.
• Olympus Corporation
• Teleflex Incorporated
• Ackermann Instrumente GmbH
• KARL STORZ GmbH
• Medtronic Plc.
• Siemens Healthineers AG

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The lung cancer surgery market is currently undergoing transformative changes as advancements in surgical techniques and technology redefine treatment approaches and patient outcomes. Beyond traditional methods, such as open surgery and chemotherapy, there is growing recognition of the potential of innovative surgical devices and personalized medicine to enhance surgical precision and improve survival rates. Ongoing research and development efforts are focusing on expanding the application of minimally invasive procedures like video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, which offer reduced recovery times and minimized post-operative complications”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Lung Cancer Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Thoracotomy (Lobectomy, Sleeve Resection, Segmentectomy, Pneumonectomy), Minimally Invasive Surgeries), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Region & Competition 2021-2031F”, has evaluated the future growth potential of Global Lung Cancer Surgery Market and provides statistics & information on market size, structure and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Lung Cancer Surgery Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]